Huawei has pushed a notable health update to its Watch GT 6 Pro, adding a new tool aimed at assessing diabetes risk without a needle or a sensor stuck to your skin. It’s the kind of feature smartwatch buyers have been asking for for years, and Huawei is now first out of the gate, at least in the way it’s presenting it.
The update was unveiled at the World Health Expo 2026 in Dubai, and it brings a new “Diabetes Risk” app to the Watch GT 6 Pro. The important detail is what the watch is and isn’t doing. This is not a blood glucose meter on your wrist, and it won’t give you a direct mmol/L or mg/dL number.
Instead, Huawei says the system relies on the watch’s photoplethysmography, or PPG, which tracks changes in blood volume, alongside other sensors. The watch then analyzes multiple metrics over a period of three to 14 days. After that window, the Diabetes Risk app presents the result.
That framing matters, because it sets expectations. What Huawei is describing is a longer view based on patterns the watch can observe, rather than a real-time blood sugar reading you could compare to a finger prick. For someone who wants a quick, precise number, this won’t replace the familiar routines of test strips or continuous glucose monitoring.
There are also practical limits before anyone gets carried away. The Watch GT 6 Pro isn’t available in the United States, so a large chunk of the smartwatch market won’t be able to use the feature at all.
And even where the watch is sold, the claims still sit in the “trust, but verify” category. The feature hasn’t been independently tested here, and it hasn’t been put head-to-head against an invasive continuous glucose monitoring product. Until that happens, the sensible approach is to treat the results as informative signals, not medical-grade answers.
Huawei itself positions the tool as something that doesn’t replace clinical testing. If the company’s accuracy claims hold up under scrutiny, it could still be meaningful: a mainstream smartwatch using everyday sensors to flag risk trends may encourage earlier attention and more informed conversations with healthcare professionals.
For now, the update is an intriguing step, paired with the kind of caveats that tend to follow genuinely new health features on consumer devices.
